{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:19:07Z","timestamp":1784945947499,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cSara Borrell\u201d of the Instituto de Salud Carlos III","award":["CD21\/00067"],"award-info":[{"award-number":["CD21\/00067"]}]},{"DOI":"10.13039\/100009042","name":"Universidad de Sevilla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u2018Miguel Servet\u2019 program of the Instituto de Salud Carlos III","award":["CP19\/00031"],"award-info":[{"award-number":["CP19\/00031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-00970-9","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:57:24Z","timestamp":1746806244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Data-driven characterization of distinct cognitive subtypes in Parkinson\u2019s disease dementia"],"prefix":"10.1038","volume":"11","author":[{"given":"Miguel A.","family":"Labrador-Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Silva-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel J.","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"970_CR1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov. Disord. 22, 1689\u20131707 (2007).","journal-title":"Mov. Disord."},{"key":"970_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M. & Morris, J. G. The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837\u2013844 (2008).","journal-title":"Mov. Disord."},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson, P., Westman, E., Ballard, C. & Aarsland, D. Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 11, 697\u2013707 (2012).","journal-title":"Lancet Neurol."},{"key":"970_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","volume":"60","author":"D Aarsland","year":"2003","unstructured":"Aarsland, D., Andersen, K., Larsen, J. P. & Lolk, A. Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 60, 387\u2013392 (2003).","journal-title":"Arch. Neurol."},{"key":"970_CR5","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/mds.29918","volume":"39","author":"LL Gibson","year":"2024","unstructured":"Gibson, L. L. et al. Risk of Dementia in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Mov. Disord. 39, 1697\u20131709 (2024).","journal-title":"Mov. Disord."},{"key":"970_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/jnnp.2006.108076","volume":"78","author":"K Bronnick","year":"2007","unstructured":"Bronnick, K., Emre, M., Lane, R., Tekin, S. & Aarsland, D. Profile of cognitive impairment in dementia associated with Parkinson\u2019s disease compared with Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatry 78, 1064\u20131068 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"970_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mds.20726","volume":"21","author":"CC Janvin","year":"2006","unstructured":"Janvin, C. C. et al. Cognitive profiles of individual patients with Parkinson\u2019s disease and dementia: comparison with dementia with lewy bodies and Alzheimer\u2019s disease. Mov. Disord. 21, 337\u2013342 (2006).","journal-title":"Mov. Disord."},{"key":"970_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","volume":"78","author":"D Aarsland","year":"2007","unstructured":"Aarsland, D. et al. Neuropsychiatric symptoms in patients with Parkinson\u2019s disease and dementia: frequency, profile and associated care giver stress. J. Neurol. Neurosurg. Psychiatry 78, 36\u201342 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s00415-010-5453-3","volume":"257","author":"S Varanese","year":"2010","unstructured":"Varanese, S. et al. Fluctuating cognition and different cognitive and behavioural profiles in Parkinson\u2019s disease with dementia: comparison of dementia with Lewy bodies and Alzheimer\u2019s disease. J. Neurol. 257, 1004\u20131011 (2010).","journal-title":"J. Neurol."},{"key":"970_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday, G. M., Leverenz, J. B., Schneider, J. S. & Adler, C. H. The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov. Disord. 29, 634\u2013650 (2014).","journal-title":"Mov. Disord."},{"key":"970_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JPD-191766","volume":"10","author":"CH Chen","year":"2020","unstructured":"Chen, C. H., Lee, B. C. & Lin, C. H. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson\u2019s Disease. J. Parkinsons Dis. 10, 77\u201388 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"970_CR12","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/brain\/awu201","volume":"137","author":"C Nombela","year":"2014","unstructured":"Nombela, C. et al. Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain 137, 2743\u20132758 (2014).","journal-title":"Brain"},{"key":"970_CR13","doi-asserted-by":"publisher","first-page":"e0175560","DOI":"10.1371\/journal.pone.0175560","volume":"12","author":"I Huertas","year":"2017","unstructured":"Huertas, I. et al. Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson\u2019s disease. PLoS One 12, e0175560 (2017).","journal-title":"PLoS One"},{"key":"970_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fneur.2018.00394","volume":"9","author":"F Sampedro","year":"2018","unstructured":"Sampedro, F., Marin-Lahoz, J., Martinez-Horta, S., Pagonabarraga, J. & Kulisevsky, J. Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline. Front. Neurol. 9, 394 (2018).","journal-title":"Front. Neurol."},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2018.08.027","volume":"73","author":"GG Miranda","year":"2019","unstructured":"Miranda, G. G., Rodrigue, K. M. & Kennedy, K. M. Frontoparietal cortical thickness mediates the effect of COMT Val(158)Met polymorphism on age-associated executive function. Neurobiol. Aging 73, 104\u2013114 (2019).","journal-title":"Neurobiol. Aging"},{"key":"970_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.parkreldis.2012.04.028","volume":"18","author":"Y Compta","year":"2012","unstructured":"Compta, Y. et al. Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson\u2019s disease and related dementia. Parkinsonism Relat. Disord. 18, 941\u2013947 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"970_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.25286","volume":"28","author":"H Shimada","year":"2013","unstructured":"Shimada, H. et al. beta-Amyloid in Lewy body disease is related to Alzheimer\u2019s disease-like atrophy. Mov. Disord. 28, 169\u2013175 (2013).","journal-title":"Mov. Disord."},{"key":"970_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/jnnp-2015-312690","volume":"87","author":"CT McMillan","year":"2016","unstructured":"McMillan, C. T. & Wolk, D. A. Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 87, 1112\u20131122 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"970_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo, J. B. et al. Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol. 131, 393\u2013409 (2016).","journal-title":"Acta Neuropathol."},{"key":"970_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00401-019-02071-3","volume":"138","author":"A Raunio","year":"2019","unstructured":"Raunio, A. et al. Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85. Acta Neuropathol. 138, 771\u2013782 (2019).","journal-title":"Acta Neuropathol."},{"key":"970_CR21","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith, C. et al. Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J. Neurol. Neurosurg. Psychiatry 90, 1234\u20131243 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"970_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.27867","volume":"35","author":"DG Coughlin","year":"2020","unstructured":"Coughlin, D. G., Hurtig, H. I. & Irwin, D. J. Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases. Mov. Disord. 35, 5\u201319 (2020).","journal-title":"Mov. Disord."},{"key":"970_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000341998","volume":"11","author":"AA Kehagia","year":"2013","unstructured":"Kehagia, A. A., Barker, R. A. & Robbins, T. W. Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis. Neurodegener. Dis. 11, 79\u201392 (2013).","journal-title":"Neurodegener. Dis."},{"key":"970_CR24","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/mds.22007","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga, J. et al. Parkinson\u2019s disease-cognitive rating scale: a new cognitive scale specific for Parkinson\u2019s disease. Mov. Disord. 23, 998\u20131005 (2008).","journal-title":"Mov. Disord."},{"key":"970_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","volume":"46","author":"J Pagonabarraga","year":"2012","unstructured":"Pagonabarraga, J. & Kulisevsky, J. Cognitive impairment and dementia in Parkinson\u2019s disease. Neurobiol. Dis. 46, 590\u2013596 (2012).","journal-title":"Neurobiol. Dis."},{"key":"970_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger, B. N. et al. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat. Disord. 20, 525\u2013529 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"970_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JAD-210114","volume":"81","author":"Q Tong","year":"2021","unstructured":"Tong, Q. & Chen, L. Associations of Alzheimer\u2019s Disease Neuropathologic Changes with Clinical Presentations of Parkinson\u2019s Disease. J. Alzheimers Dis. 81, 201\u2013207 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"970_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/nan.12659","volume":"46","author":"DG Coughlin","year":"2020","unstructured":"Coughlin, D. G. et al. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 46, 707\u2013721 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"970_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2020.08.003","volume":"96","author":"DG Coughlin","year":"2020","unstructured":"Coughlin, D. G. et al. Multimodal in vivo and postmortem assessments of tau in Lewy body disorders. Neurobiol. Aging 96, 137\u2013147 (2020).","journal-title":"Neurobiol. Aging"},{"key":"970_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.25811","volume":"88","author":"DJ Irwin","year":"2020","unstructured":"Irwin, D. J. et al. Evolution of Alzheimer\u2019s Disease Cerebrospinal Fluid Biomarkers in Early Parkinson\u2019s Disease. Ann. Neurol. 88, 574\u2013587 (2020).","journal-title":"Ann. Neurol."},{"key":"970_CR31","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/mds.22488","volume":"24","author":"C Sanchez-Castaneda","year":"2009","unstructured":"Sanchez-Castaneda, C. et al. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson\u2019s disease with dementia. Mov. Disord. 24, 1740\u20131746 (2009).","journal-title":"Mov. Disord."},{"key":"970_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/mds.22873","volume":"25","author":"C Sanchez-Castaneda","year":"2010","unstructured":"Sanchez-Castaneda, C. et al. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson\u2019s disease with dementia. Mov. Disord. 25, 615\u2013622 (2010).","journal-title":"Mov. Disord."},{"key":"970_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/hbm.23080","volume":"37","author":"C Gasca-Salas","year":"2016","unstructured":"Gasca-Salas, C., Clavero, P., Garcia-Garcia, D., Obeso, J. A. & Rodriguez-Oroz, M. C. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson\u2019s disease patients with mild cognitive impairment. Hum. Brain Mapp. 37, 968\u2013977 (2016).","journal-title":"Hum. Brain Mapp."},{"key":"970_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neurobiolaging.2016.12.002","volume":"51","author":"T Gorbach","year":"2017","unstructured":"Gorbach, T. et al. Longitudinal association between hippocampus atrophy and episodic-memory decline. Neurobiol. Aging 51, 167\u2013176 (2017).","journal-title":"Neurobiol. Aging"},{"key":"970_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli, R. et al. Parkinson\u2019s disease is associated with hippocampal atrophy. Mov. Disord. 18, 784\u2013790 (2003).","journal-title":"Mov. Disord."},{"key":"970_CR36","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/brain\/awu159","volume":"137","author":"R Gonz\u00e1lez-Redondo","year":"2014","unstructured":"Gonz\u00e1lez-Redondo, R. et al. Grey matter hypometabolism and atrophy in Parkinson\u2019s disease with cognitive impairment: a two-step process. Brain 137, 2356\u20132367 (2014).","journal-title":"Brain"},{"key":"970_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2018.11.004","volume":"21","author":"F Albrecht","year":"2019","unstructured":"Albrecht, F., Ballarini, T., Neumann, J. & Schroeter, M. L. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson\u2019s disease: A whole-brain multimodal imaging meta-analysis. Neuroimage Clin. 21, 101594 (2019).","journal-title":"Neuroimage Clin."},{"key":"970_CR38","doi-asserted-by":"crossref","unstructured":"Silva-Rodr\u00edguez J. et al. Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging. 52, 2002\u20132014 (2025).","DOI":"10.1007\/s00259-025-07070-z"},{"key":"970_CR39","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","volume":"71","author":"IF Mata","year":"2014","unstructured":"Mata, I. F. et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol. 71, 1405\u20131412 (2014).","journal-title":"JAMA Neurol."},{"key":"970_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","volume":"6","author":"KC Paul","year":"2016","unstructured":"Paul, K. C. et al. APOE, MAPT, and COMT and Parkinson\u2019s Disease Susceptibility and Cognitive Symptom Progression. J. Parkinsons Dis. 6, 349\u2013359 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"970_CR41","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1093\/brain\/awu143","volume":"137","author":"N Zokaei","year":"2014","unstructured":"Zokaei, N. et al. Visual short-term memory deficits associated with GBA mutation and Parkinson\u2019s disease. Brain 137, 2303\u20132311 (2014).","journal-title":"Brain"},{"key":"970_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata, I. F. et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson\u2019s disease. Mov. Disord. 31, 95\u2013102 (2016).","journal-title":"Mov. Disord."},{"key":"970_CR43","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"RS Weil","year":"2016","unstructured":"Weil, R. S. et al. Visual dysfunction in Parkinson\u2019s disease. Brain 139, 2827\u20132843 (2016).","journal-title":"Brain"},{"key":"970_CR44","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann, J. et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132, 1783\u20131794 (2009).","journal-title":"Brain"},{"key":"970_CR45","doi-asserted-by":"publisher","first-page":"725 .e721","DOI":"10.1016\/j.neurobiolaging.2013.08.012","volume":"35","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Clinical profiles of Parkinson\u2019s disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiol. Aging 35, 725 .e721\u2013 e726 (2014).","journal-title":"Neurobiol. Aging"},{"key":"970_CR46","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/mds.28195","volume":"35","author":"S Petrucci","year":"2020","unstructured":"Petrucci, S. et al. GBA-Related Parkinson\u2019s Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort. Mov. Disord. 35, 2106\u20132111 (2020).","journal-title":"Mov. Disord."},{"key":"970_CR47","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1007\/s00415-024-12374-5","volume":"271","author":"CW Chang","year":"2024","unstructured":"Chang, C. W., Tan, C. H., Hong, W. P. & Yu, R. L. GBA moderates cognitive reserve\u2019s effect on cognitive function in patients with Parkinson\u2019s disease. J. Neurol. 271, 4392\u20134405 (2024).","journal-title":"J. Neurol."},{"key":"970_CR48","doi-asserted-by":"crossref","unstructured":"Caminiti, S. P. et al. Combined detrimental effect of male sex and GBA1 variants on cognitive decline in Parkinson\u2019s Disease. medRxiv, http:\/\/www.medrxiv.org\/content\/10.1101\/2024.04.02.24305191v1 (2024).","DOI":"10.1101\/2024.04.02.24305191"},{"key":"970_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neuint.2015.12.004","volume":"93","author":"M Barkhuizen","year":"2016","unstructured":"Barkhuizen, M., Anderson, D. G. & Grobler, A. F. Advances in GBA-associated Parkinson\u2019s disease-Pathology, presentation and therapies. Neurochem. Int. 93, 6\u201325 (2016).","journal-title":"Neurochem. Int."},{"key":"970_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.11.018","volume":"22","author":"A Lenka","year":"2016","unstructured":"Lenka, A., Hegde, S., Jhunjhunwala, K. R. & Pal, P. K. Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson\u2019s disease: A review. Parkinsonism Relat. Disord. 22, 1\u20138 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"970_CR51","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/acn3.51164","volume":"7","author":"RN Alcalay","year":"2020","unstructured":"Alcalay, R. N. et al. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson\u2019s patients. Ann. Clin. Transl. Neurol. 7, 1816\u20131830 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"970_CR52","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"RN Alcalay","year":"2015","unstructured":"Alcalay, R. N. et al. Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations. Brain 138, 2648\u20132658 (2015).","journal-title":"Brain"},{"key":"970_CR53","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1212\/WNL.0000000000201418","volume":"100","author":"L Oftedal","year":"2023","unstructured":"Oftedal, L. et al. Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease. Neurology 100, e388\u2013e395 (2023).","journal-title":"Neurology"},{"key":"970_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neurobiolaging.2021.10.011","volume":"111","author":"AJ Dugan","year":"2022","unstructured":"Dugan, A. J. et al. Association between WWOX\/MAF variants and dementia-related neuropathologic endophenotypes. Neurobiol. Aging 111, 95\u2013106 (2022).","journal-title":"Neurobiol. Aging"},{"key":"970_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106887","volume":"208","author":"YT Yuan","year":"2025","unstructured":"Yuan, Y. T., Hong, W. P., Tan, C. H. & Yu, R. L. Influence of WWOX\/MAF genes on cognitive performance in patients with Parkinson\u2019s disease. Neurobiol. Dis. 208, 106887 (2025).","journal-title":"Neurobiol. Dis."},{"key":"970_CR56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s40572-017-0143-2","volume":"4","author":"SM Fleming","year":"2017","unstructured":"Fleming, S. M. Mechanisms of Gene-Environment Interactions in Parkinson\u2019s Disease. Curr. Environ. Health Rep. 4, 192\u2013199 (2017).","journal-title":"Curr. Environ. Health Rep."},{"key":"970_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/brainsci11030361","volume":"11","author":"RL Yu","year":"2021","unstructured":"Yu, R. L., Tu, S. C., Wu, R. M., Lu, P. A. & Tan, C. H. Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson\u2019s Disease. Brain Sci. 11, 361 (2021).","journal-title":"Brain Sci."},{"key":"970_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","volume":"13","author":"SP Yun","year":"2018","unstructured":"Yun, S. P. et al. \u03b1-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol. Neurodegener. 13, 1 (2018).","journal-title":"Mol. Neurodegener."},{"key":"970_CR59","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2020-323646","volume":"91","author":"BM Jacobs","year":"2020","unstructured":"Jacobs, B. M. et al. Parkinson\u2019s disease determinants, prediction and gene-environment interactions in the UK Biobank. J. Neurol. Neurosurg. Psychiatry 91, 1046\u20131054 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"970_CR60","first-page":"263083","volume":"2010","author":"P McNamara","year":"2010","unstructured":"McNamara, P., Stavitsky, K., Durso, R. & Harris, E. The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson\u2019s Disease: Patient versus Examiner Estimates. Parkinsons Dis. 2010, 263083 (2010).","journal-title":"Parkinsons Dis."},{"key":"970_CR61","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1192\/bjo.2022.611","volume":"8","author":"YR Chen","year":"2022","unstructured":"Chen, Y. R. et al. Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson\u2019s disease with mild cognitive impairment. BJPsych Open 8, e205 (2022).","journal-title":"BJPsych Open"},{"key":"970_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.913958","volume":"14","author":"YW Yu","year":"2022","unstructured":"Yu, Y. W. et al. A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson\u2019s Disease. Front. Aging Neurosci. 14, 913958 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"970_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnhum.2019.00269","volume":"13","author":"M Statucka","year":"2019","unstructured":"Statucka, M. & Cohn, M. Origins Matter: Culture Impacts Cognitive Testing in Parkinson\u2019s Disease. Front. Hum. Neurosci. 13, 269 (2019).","journal-title":"Front. Hum. Neurosci."},{"key":"970_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.103924","volume":"93","author":"HJ Yi","year":"2024","unstructured":"Yi, H. J., Tan, C. H., Hong, W. P. & Yu, R. L. Development and validation of the geriatric apathy scale: Examining multi-dimensional apathy profiles in a neurodegenerative population with cultural considerations. Asian J. Psychiatr. 93, 103924 (2024).","journal-title":"Asian J. Psychiatr."},{"key":"970_CR65","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker I.","year":"2011","unstructured":"Parkinson Progression Marker I. The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"970_CR66","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek, K. et al. The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann. Clin. Transl. Neurol. 5, 1460\u20131477 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"970_CR67","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins, G. T. et al. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov. Disord. 28, 668\u2013670 (2013).","journal-title":"Mov. Disord."},{"key":"970_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1023-6","volume":"18","author":"KA Bjornara","year":"2018","unstructured":"Bjornara, K. A., Pihlstrom, L., Dietrichs, E. & Toft, M. Risk variants of the alpha-synuclein locus and REM sleep behavior disorder in Parkinson\u2019s disease: a genetic association study. BMC Neurol. 18, 20 (2018).","journal-title":"BMC Neurol."},{"key":"970_CR69","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00401-016-1552-2","volume":"131","author":"JH Kang","year":"2016","unstructured":"Kang, J. H. et al. CSF biomarkers associated with disease heterogeneity in early Parkinson\u2019s disease: the Parkinson\u2019s Progression Markers Initiative study. Acta Neuropathol. 131, 935\u2013949 (2016).","journal-title":"Acta Neuropathol."},{"key":"970_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/genes12030423","volume":"12","author":"S Koks","year":"2021","unstructured":"Koks, S., Pfaff, A. L., Bubb, V. J. & Quinn, J. P. Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes. Genes 12, 423 (2021).","journal-title":"Genes"},{"key":"970_CR71","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/j.semnuclmed.2010.03.002","volume":"40","author":"J Seibyl","year":"2010","unstructured":"Seibyl, J., Marek, K. & Zubal, I. G. The role of the core imaging laboratory in multicenter trials. Semin Nucl. Med. 40, 338\u2013346 (2010).","journal-title":"Semin Nucl. Med."},{"key":"970_CR72","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"Ray, N. J. et al. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain 141, 165\u2013176 (2018).","journal-title":"Brain"},{"key":"970_CR73","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11682-018-9922-0","volume":"13","author":"AS Mihaescu","year":"2019","unstructured":"Mihaescu, A. S. et al. Brain degeneration in Parkinson\u2019s disease patients with cognitive decline: a coordinate-based meta-analysis. Brain Imaging Behav. 13, 1021\u20131034 (2019).","journal-title":"Brain Imaging Behav."},{"key":"970_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104831","volume":"139","author":"JB Pereira","year":"2020","unstructured":"Pereira, J. B. et al. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson\u2019s disease. Neurobiol. Dis. 139, 104831 (2020).","journal-title":"Neurobiol. Dis."},{"key":"970_CR75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2021.05.027","volume":"88","author":"MJ Grothe","year":"2021","unstructured":"Grothe, M. J. et al. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson\u2019s disease: Imaging results from the COPPADIS study. Parkinsonism Relat. Disord. 88, 68\u201375 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"970_CR76","doi-asserted-by":"crossref","unstructured":"Labrador-Espinosa, M. A., Silva-Rodr\u00edguez, J., Reina-Castillo, M. I., Mir, P. & Grothe, M. J. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-\u03b2 Status in Parkinson\u2019s disease-Related Cognitive Decline. Mov Disorders. 38, 1871\u20131880 (2023).","DOI":"10.1002\/mds.29564"},{"key":"970_CR77","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jalz.2017.01.009","volume":"13","author":"D Wolf","year":"2017","unstructured":"Wolf, D., Bocchetta, M., Preboske, G. M., Boccardi, M. & Grothe, M. J. Alzheimer\u2019s Disease Neuroimaging I. Reference standard space hippocampus labels according to the European Alzheimer\u2019s Disease Consortium-Alzheimer\u2019s Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry. Alzheimers Dement 13, 893\u2013902 (2017).","journal-title":"Alzheimers Dement"},{"key":"970_CR78","doi-asserted-by":"crossref","unstructured":"Grothe, M. J., Kilimann, I., Grinberg, L., Heinsen, H. & Teipel, S. In Vivo Volumetry of the Cholinergic Basal Forebrain. In: Perneczky R., ed. Biomarkers for Preclinical Alzheimer\u2019s Disease. (Springer, 2018) pp. 213\u2013232.","DOI":"10.1007\/978-1-4939-7674-4_15"},{"key":"970_CR79","doi-asserted-by":"crossref","unstructured":"Fritz, H. J. et al. The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles. Hum. Brain. Mapp. 40, 868\u2013878 (2019).","DOI":"10.1002\/hbm.24417"},{"key":"970_CR80","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biopsych.2020.01.016","volume":"88","author":"M Habes","year":"2020","unstructured":"Habes, M. et al. Disentangling Heterogeneity in Alzheimer\u2019s Disease and Related Dementias Using Data-Driven Methods. Biol. Psychiatry 88, 70\u201382 (2020).","journal-title":"Biol. Psychiatry"},{"key":"970_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-021-00785-9","volume":"13","author":"F Levin","year":"2021","unstructured":"Levin, F. et al. Data-driven FDG-PET subtypes of Alzheimer\u2019s disease-related neurodegeneration. Alzheimers Res. Ther. 13, 49 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"970_CR82","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1109\/TPAMI.1979.4766909","volume":"1","author":"DL Davies","year":"1979","unstructured":"Davies, D. L. & Bouldin, D. W. A cluster separation measure. IEEE Trans. Pattern Anal. Mach. Intell. 1, 224\u2013227 (1979).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"970_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw, P. J. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J. Computational Appl. Math. 20, 53\u201365 (1987).","journal-title":"J. Computational Appl. Math."},{"key":"970_CR84","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/opo.12131","volume":"34","author":"RA Armstrong","year":"2014","unstructured":"Armstrong, R. A. When to use the Bonferroni correction. Ophthalmic Physiol. Opt. 34, 502\u2013508 (2014).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"970_CR85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hbm.23018","volume":"37","author":"MJ Grothe","year":"2016","unstructured":"Grothe, M. J. & Teipel, S. J. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer\u2019s disease correspond to dissociable functional brain networks. Hum. Brain Mapp. 37, 35\u201353 (2016).","journal-title":"Hum. Brain Mapp."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00970-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00970-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00970-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T17:03:25Z","timestamp":1746810205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00970-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-00970-9","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}